Results 211 to 217 of about 20,494 (217)

Pityriasis rosea, human herpesvirus 6 infection and pregnancy

Journal of Medical Virology, 2022
we read the interesting article by Bortolotti et al. on the relationship between human herpesvirus 6 (HHV-6) infection and intrauterine growth restriction (IUGR)1 that prompted us to describe our experience about pityriasis rosea (PR) occurring during ...
F. Drago, G. Ciccarese, S. Casazza, A. Parodi   +3 more
semanticscholar   +1 more source

Utility of IL‐36 immunostaining in distinguishing psoriasis from pityriasis rosea and pityriasis lichenoides

Journal of cutaneous pathology
Psoriasis is an inflammatory skin disease driven by upregulation of cytokines in the Th17 pathway, including interleukin‐36 (IL‐36). Previous studies have highlighted the utility of IL‐36 immunostaining for psoriasis compared to spongiotic dermatitis and
M. Ibraheim, Jeffrey P North
semanticscholar   +1 more source

Pityriasis rosea: dermoscopic features in Uganda

International Journal of Dermatology
The study aimed to describe the dermoscopic features of pityriasis rosea among patients attending the skin clinic at Mbarara Regional Referral Hospital.
Paul K. Kiptis, S. Mirembe, Gladys Aloyomola, G. Mulyowa   +3 more
semanticscholar   +1 more source

Clinicopathologic features of pityriasis rosea‐like drug eruption secondary to imatinib: A case report and review of the literature

Journal of cutaneous pathology
Pityriasis rosea is an acute, self‐limited exanthem that typically occurs in adolescence and young adulthood, classically featuring ovoid erythematous and scaly lesions on the trunk and proximal extremities. While its cause is not definitively known, the
Joseph S Durgin, Carli P Whittington, Jane Harrell, Julie E. Mervak, Emily H Smith   +4 more
semanticscholar   +1 more source

AstraZeneca COVID-19 vaccine-related pityriasis rosea

Reactions weekly, 2023

semanticscholar   +1 more source